TenCure / News and Events / Interview with Dr. Tamar Tennenbaum about Israeli Biotech Industry and the success of HealOr

Press Room

Interview with Dr. Tamar Tennenbaum about Israeli Biotech Industry and the success of HealOr

Jerusalem News, 23 July 2010.

Download PDF

Skin Cancer

Skin cancer is the most common form of cancer, accounting for at least half of all other c...

Colon Cancer

Colorectal (Colon) cancer is the third most common type of cancer.

Pancreatic Cancer

Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United S...

Skin Cancer

Skin cancer is the most common form of cancer, accounting for at least half of all other c...

Colon Cancer

Colorectal (Colon) cancer is the third most common type of cancer.

Pancreatic Cancer

Pancreatic cancer is the fourth most common cause of cancer-related deaths in the United S...

About TenCure | Our Team | Cancer | Diabetes | Contact Us

Pioneering a unique, comprehensive approach to cancer drug development, TenCure is establishing a first in class, diverse pipeline of oncology therapies, with a specific focus on niche markets.

Site by: Media Processor